Transomic Technologies was formed in 2011 for the purpose of supplying life science researchers with next-generation gene modulation tools derived from the latest advancements in biotechnology.
Today, Transomic has an extensive inventory of CRISPR-Cas9 reagents for gene editing, RNAi tools for gene knockdown and a comprehensive offering of gene overexpression systems. Our extensive portfolio of genomic tools, combined with our knowledge and process-proven platforms, makes Transomic a top genomic solutions company for top genomic labs.
We have been serving pharma, biotech, and academic researchers across the globe for over 7 years.